Literature DB >> 2950715

Calcineurin in human brain and its relation to extrapyramidal system. Immunohistochemical study on postmortem human brains.

S Goto, Y Matsukado, Y Mihara, N Inoue, E Miyamoto.   

Abstract

Calcineurin immunoreactivity has been successfully detected in formalin-fixed paraffin-embedded postmortem human brain tissue using the peroxidase-antiperoxidase method. We have examined two autopsy cases with Huntington's disease (HD), three cases with Parkinson's disease, and two senile patients as controls. In the controls, calcineurin immunoreactivity was present in neuronal cells only and highly concentrated in the caudate nucleus, putamen, globus pallidus (striato-pallidal pathway), substantia nigra (striato-nigral pathway) and hippocampal formation. These localizations were similar to those identified in rat brain. There was a marked depletion of neurons containing calcineurin in the caudate nucleus and putamen, and a marked reduction of calcineurin-immunoreactive nerve fibers in the globus pallidus and substantia nigra were found in the cases with HD, but not in those with Parkinson's disease. These findings suggest that calcineurin can be a useful and specific index of neuronal degeneration in the caudato-putamen resulting from extrapyramidal disease, and that the calcineurin-immunostaining method can be a valuable tool for clarifying the anatomy of the human extrapyramidal system.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2950715     DOI: 10.1007/bf00685977

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  15 in total

1.  The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes.

Authors:  L A Sternberger; P H Hardy; J J Cuculis; H G Meyer
Journal:  J Histochem Cytochem       Date:  1970-05       Impact factor: 2.479

2.  The distribution of calcineurin in rat brain by light and electron microscopic immunohistochemistry and enzyme-immunoassay.

Authors:  S Goto; Y Matsukado; Y Mihara; N Inoue; E Miyamoto
Journal:  Brain Res       Date:  1986-11-05       Impact factor: 3.252

3.  DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1.

Authors:  H C Hemmings; P Greengard; H Y Tung; P Cohen
Journal:  Nature       Date:  1984 Aug 9-15       Impact factor: 49.962

4.  Discovery of a Ca2+- and calmodulin-dependent protein phosphatase: probable identity with calcineurin (CaM-BP80).

Authors:  A A Stewart; T S Ingebritsen; A Manalan; C B Klee; P Cohen
Journal:  FEBS Lett       Date:  1982-01-11       Impact factor: 4.124

5.  Isolation and characterization of bovine brain calcineurin: a calmodulin-stimulated protein phosphatase.

Authors:  C B Klee; M H Krinks; A S Manalan; P Cohen; A A Stewart
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

6.  Calcineurin is a calcium ion-dependent, calmodulin-stimulated protein phosphatase.

Authors:  N K Tonks; P Cohen
Journal:  Biochim Biophys Acta       Date:  1983-09-14

7.  On the origin of substance P and glutamic acid decarboxylase (GAD) in the substantia nigra.

Authors:  M J Brownstein; E A Mroz; M L Tappaz; S E Leeman
Journal:  Brain Res       Date:  1977-10-28       Impact factor: 3.252

8.  Dephosphorylation of microtubule-associated protein 2, tau factor, and tubulin by calcineurin.

Authors:  S Goto; H Yamamoto; K Fukunaga; T Iwasa; Y Matsukado; E Miyamoto
Journal:  J Neurochem       Date:  1985-07       Impact factor: 5.372

9.  The protein phosphatases involved in cellular regulation. 5. Purification and properties of a Ca2+/calmodulin-dependent protein phosphatase (2B) from rabbit skeletal muscle.

Authors:  A A Stewart; T S Ingebritsen; P Cohen
Journal:  Eur J Biochem       Date:  1983-05-02

10.  Immunocytochemical localization of calmodulin and a heat-labile calmodulin-binding protein (CaM-BP80) in basal ganglia of mouse brain.

Authors:  J G Wood; R W Wallace; J N Whitaker; W Y Cheung
Journal:  J Cell Biol       Date:  1980-01       Impact factor: 10.539

View more
  16 in total

1.  Differential expression and redox proteomics analyses of an Alzheimer disease transgenic mouse model: effects of the amyloid-β peptide of amyloid precursor protein.

Authors:  R A S Robinson; M B Lange; R Sultana; V Galvan; J Fombonne; O Gorostiza; J Zhang; G Warrier; J Cai; W M Pierce; D E Bredesen; D A Butterfield
Journal:  Neuroscience       Date:  2011-01-09       Impact factor: 3.590

2.  Immunohistochemical visualization of afferent nerve terminals in human globus pallidus and its alteration in neostriatal neurodegenerative disorders.

Authors:  S Goto; A Hirano; R R Rojas-Corona
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

3.  A comparative immunohistochemical study of calcineurin and S-100 protein in mammalian and avian brains.

Authors:  S Goto; Y Matsukado; S Uemura; Y Mihara; N Inoue; J Ikeda; E Miyamoto
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

4.  Calcineurin is associated with the cytoskeleton of cultured neurons and has a role in the acquisition of polarity.

Authors:  A Ferreira; R Kincaid; K S Kosik
Journal:  Mol Biol Cell       Date:  1993-12       Impact factor: 4.138

5.  Immunocytochemical localization of calcineurin in the adult and developing primary visual cortex of cats.

Authors:  S Goto; W Singer; Q Gu
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

6.  Inhibition of Calcineurin A by FK506 Suppresses Seizures and Reduces the Expression of GluN2B in Membrane Fraction.

Authors:  Yuetao Wen; Pengfei Fu; Kunlun Wu; Kaichuang Si; Yanfeng Xie; Wei Dan; Yan Zhan; Quanhong Shi
Journal:  Neurochem Res       Date:  2017-03-15       Impact factor: 3.996

7.  Calcineurin immunoreactivity in striatonigral degeneration.

Authors:  S Goto; A Hirano; R R Rojas-Corona
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

8.  Calcium phosphatase calcineurin influences tau metabolism.

Authors:  Celeste M Karch; Amanda T Jeng; Alison M Goate
Journal:  Neurobiol Aging       Date:  2012-06-06       Impact factor: 4.673

9.  Calcineurin inhibition at the clinical phase of prion disease reduces neurodegeneration, improves behavioral alterations and increases animal survival.

Authors:  Abhisek Mukherjee; Diego Morales-Scheihing; Dennisse Gonzalez-Romero; Kristi Green; Giulio Taglialatela; Claudio Soto
Journal:  PLoS Pathog       Date:  2010-10-07       Impact factor: 6.823

Review 10.  A central role for calcineurin in protein misfolding neurodegenerative diseases.

Authors:  Syed Zahid Ali Shah; Tariq Hussain; Deming Zhao; Lifeng Yang
Journal:  Cell Mol Life Sci       Date:  2016-09-28       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.